Overview

Esmolol to Treat the Hemodynamic Effects of Septic Shock

Status:
Terminated
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine the effects of controlling the heart rate of patients with septic shock using an intravenous medication called esmolol.
Phase:
Phase 2
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborator:
American Heart Association
Treatments:
Esmolol